Markets live chat transcript for the chat ending at 12:09 on 22 Apr 2009. Participants in this chat were: Neil Hume, FT (NH) Paul Murphy, FT (PM)
PSNB for 09/10
Current budget balance 08/08 and 09/10
Net debt 08/09 and 09/10
growth forecast for 2009 to a figure in line with
the consensus, whilst still clinging on to growth
above 1% for 2010. But we continue to believe
that the recession will persist in 2010 mainly
due to weakness in the household sector.
borrowing figures, probably to a peak of £175bn
in 09/10, largely on the back of a provision for
the costs of the banking interventions of up to
£60bn, and a poorer-than-expected tax take. But
even these estimates might be too rosy, given
our view on the recession’s length and severity.
the scale of the necessary fiscal tightening that
lies ahead. The figures are likely to show a large
deficit in 2012/13, despite the fiscal tightening
measures that will have kicked in by then.
GDP are likely to rise above 70%. Our more
negative forecasts for borrowing and growth
imply a ratio of close to 100% in 2012/3.
http://pv.webbyawards.com/
Register here:
http://pv.webbyawards.com/account/signup
Then go here to actually vote:
http://pv.webbyawards.com/ballot/home/1
you will have to scroll down and find the Marketplace categories – and then find “business – blog”
You then click the button next to FT Alphaville.
You can also leave a comment to encourage others and help the judges make their sharp minds up.
rose by less than expected in March, although the total in unemployment number
surged higher and government borrowing hit a record high, data showed on
Wednesday.
Official data from the Office for National Statistics showed the
claimant count rate rose by 73,700 in March, well below forecasts for a rise of
120,000.
However, the broader ILO measure, which includes those out of work but
not claiming benefits, spiked by 177,000 in the three months to February, the
biggest jump since 1991.
That pushed the level of total unemployment to its highest since early
1997, just before the Labour government took office.
British finance minister Alistair Darling is expected to announce a two
billion pound package aimed at preventing school and university leavers from
joining the dole queue and boosting services for the unemployed.
However, the government’s ability to kick-start Britain’s recession-hit
economy with further large-scale fiscal stimulus is limited by the sharp
deterioration in the public finances.
Government borrowing in the 2008/09 tax year totalled 89.958 billion
pounds, much higher than the 77.6 billion pounds forecast in the government’s
pre-budget report last November, and the highest since records began in
1946/47.
WHY?
PSNB includes public corporations, which now includes the banks operating surpluses. It was worth £12bn in 2008-09.
WHAT SHOULD WE DO?
Always check “general government net borrowing” as well as “public sector net borrowing”. If there is a big difference, we need to tell readers that the underlying situation is worse. This is particularly true if we use public sector debt figures excluding financial sector interventions, the corollary is to use GGNB nor PSNB.
AND GILTS?
This is one of the main reasons why the gilt issuance will be so much higher than the headline level of borrowing
policy stimulus has been more aggressive and 2) the domestic demand
response has been stronger and has occurred earlier than we originally
forecasted.
Our new forecasts predict real GDP growth of 8.3% in 2009 (versus 6.0%
previously) and more importantly, to reach 10.9% in 2010 (up from 9.0%),
significantly above consensus.
investment growth, especially from private investment.
In addition, we expect policymakers to eventually normalize and shift away
from aggressive policy loosening, but only when they are more assured of a
stabilization in domestic unemployment and external demand. This would give
additional insurance to the growth trajectory we foresee
stronger case for China’s growth re-rating. Since the announcement of the Rmb4 trillion fiscal
stimulus package last November, policymakers in China have been pushing the envelope on
policy easing in only one direction—for more and more. The pace of implementation of new
infrastructure investment and the scale of domestic credit expansion have been unprecedented.
However, as we have long argued, one should probably discount some of the official statistics for
quality/seasonality reasons, especially in any one particular data series. We believe the message
from the aggregate macro data along with other anecdotal evidence, such as domestic commodity
demand, is clear: the aggressive policy stimulus has been working
response from domestic demand has come in earlier and more strongly than we envisaged
previously. The strong rebound in fixed asset investment (FAI) growth which started in January-
February strengthened even further in March. This was partly as a result of rushed orders to
implement investment projects and aggressive easing in financial conditions. As previously
discussed, the newly released 1Q2009 GDP and March activity data surprised us on the upside
both in sequential and year-on-year terms (see Stronger-than-expected activity growth; rising
upside risks to our GDP forecasts, China Views, April 16). This is despite the fact that our
previous set of GDP forecasts had already incorporated a significant growth rebound in 1Q2009
and further additional strengthening in growth momentum for the rest of the year.
version recently, but compared to the US assumptions, the FSA looks like a sadistic
dominatrix. The US version can only be described as a stress-less test!
comparison with the US efforts, the FSA looks like a sadistic dominatrix. The UK test
apparently assumed a peak-to-trough decline in GDP of around 6% much like that seen in the
early 1980s (although the actual parameters have not been disclosed).
The table below shows the assumptions of the US stress test, under both the base case and
the adverse case. For comparison Ive shown the situation as of today (based on the last six
months data annualized). The adverse case looks like a pretty good description of where we
are today. Thus if any of the banks fail the stress test, they are clearly insolvent today, let
alone in a six months or a years time. Not so much a stress test, as a stress less test.
The federal bank “stress tests” rate the individual loans held by big regional banks as riskier than the complex troubled assets held by the industry titans, according to a Federal Reserve document obtained by The Associated Press.
That approach could threaten some major regional banks while making the national banks appear in better shape when the government releases the results of the tests next month.
Regulators are administering the tests to 19 large financial firms to determine which banks are healthy, which need more help and which might fail if the recession worsens.
Under one scenario, the tests assume banks will see “no further losses” on the complex securities, according to the document obtained by AP. By contrast, it estimates that individual loans will lose up to 20 percent of their value.
Regional banks are holding more individual loans and fewer of the securities Wall Street giants specialize in — complex derivatives backed by huge pools of mortgage-backed loans and other debt.
Analysts say regulators are probably favoring the largest banks because if even one failed, it would pose a grave financial risk. Banks that deal in securities are more connected to other corners of the global financial system.
The approach spelled out in the Fed document “certainly penalizes those banks that are more involved in traditional banking, which frankly have been performing better in recent months,” said Wayne Abernathy, a former Treasury Department official now with the American Bankers Association.
He said banks’ loan portfolios have lost only about 5 percent of their value so far, while the values of complex securities are down 30 to 40 percent.
The securities are held mostly by banking titans like Citigroup, JP Morgan Chase, Bank of America and Goldman Sachs. Their value is based on the performance of vast pools of underlying loans.
As defaults on the underlying loans spiked last year, investors lost confidence in the value of the assets. Individual loans have lost less value because their prices are tied more closely to actual defaults.
A Treasury Department spokesman referred questions to the Fed. A spokesman for the Federal Reserve declined comment.
In our view, Lloyds is one of the few European banks that can say with certainty
that they are fully recapitalised. Others may be able to avoid issuing stock but this
conclusion is far from being a certainty elsewhere.
As well as having been recapitalised and de-risked through its involvement in the
UK Asset Protection Scheme, Lloyds has, in our view, a balance sheet structure
which affords more protection than most from structural margin pressures resulting
the current interest rate environment. An excess of lending over customer deposits
and the greater exposure to UK mortgages than peers, one of the fastest repricing
asset classes globally means Lloyds is differentiated relative to other banks.
The UK Government owns 43% of Lloyds and given the share price is materially
above the proposed 38.43p issuance/underwriting price for equity to replace the
preference shares, this level will not rise until conversion of “B” shares.
“A Different Proposition” dated 17 March concluded that a valuation of
100p/share was undemanding for Lloyds. We valued Lloyds by discounting 2012
normalised earnings of 16p valued at 9x less 10p/share for the net post-tax cost of
the APS, giving 110p/share. As such we adopted a 100p price target on the shares.
At that time, there was only modest value in the option to subscribe for new shares
at 38.43p. This is no longer true. Discounting our 100p price target by 10% to 90p
for timing uncertainty but moving to a “ex” subscription basis implies a revised
price target of 120p on a “cum” subscription basis. This is our new price target.
provides a degree of comfort in its own right and also underpins the dividend yield of
3.4%. While we retain concerns about the outlook for retail sales at a time of rising
unemployment, there ought to be some offsetting benefit from the collapse of Zavvi
and Woolworths. The news on gross margin is clearly positive.
migrate to the online channel, both as physical product and as downloads. At that
stage, a store network will become a liability rather than an asset. GMG will need to
manage a reduction in its estate rather than the increase it is currently pursuing in
international markets. One can exaggerate the short-term threat from the likes of
OnLive, which faces commercial as well as technical challenges.
Nevertheless, we expect services like that to become a major part of the market in the longer term. GMG is aware of the threat and is developing its online presence. The question remains: will it be able to secure the market share in the online world that it has built offline?
there is now c.11% headroom to our target price, triggering an automatic upgrade in
our recommendation from HOLD to BUY. That will be subject to review following the results presentation when we update our forecasts.
For the first time in 24 months, our UK demand forecasts have upside risk.
Until now, with macro conditions progressively deteriorating, we have argued
that weak comparatives will have little traction with a heavily-indebted
consumer, a declining housing market, rising unemployment and therefore
sharply negative consumer confidence trends. However, as we progress
through 2009, the following factors could drive upside risk to forecasts:
two-year Non-Food LFL has improved to -6.0% (from -8.6%, Q408). As the
comparatives ease during each quarter of 2009, a continuation of the -6%
two-year LFL over 2009 argues for a return to positive LFL during the 2H
2009 (Figure 10).
fading space contribution and weakening comparatives, this also suggests a return
to stable sector LFL through the 2H of 2009 and into 2010.
2009 UK sector LFL forecast raised +250bp to -4%; 2009E EPS raised +21% —
On the back of this macro analysis, we increase our 2009E LFL +250bp to
-4% (split 1H -4.4%; 2H -2.7%). This increases our UK sector EPS forecast by
+21% to +9% above consensus (2009E sector EPS -15.3% year on year).
3 Hold ratings raised to Buy (Next, Signet and Sports Direct); target prices raised on 12 stocks (see below) — underpinned by the sector’s 20% EV/EBIT discount to its long-run average. We now have 10 Buy and 4 Hold ratings across our UK coverage universe, representing an Overweight sector stance.
*LVMH CFO SAYS `SOME COMPANIES MIGHT CONSOLIDATE’ :MC FP, RM
*LVMH CFO SAYS COMPANY HAS NO SPECIFIC ACQUISITION TARGET
*LVMH CFO SAYS DIAGEO/MOET REPORTS `PURELY A MARKET RUMOR’
*LVMH SAYS NO TALKS ONGOING ABOUT SALE OF MOT HENNESSY
It is true that this brand, and the rest of the MH portfolio of luxury spirits and Champagne brands (such as Belvedere vodka, Glenmorangie Scotch whisky and Moet Champagne), are already one third owned by Diageo. Moreover, the two companies already have a loose distribution alliance, the extent of which varies market by market. But this acquisition would increase Diageo’s economic interest in the attractive Cognac category, allow it to consolidate MH’s cashflows (it currently only receives a dividend), and bring MH’s brands fully within its global distribution network.
The timing of the deal could therefore be excellent for both parties, increasing the likelihood of it going ahead. LVMH would get a good price for a business that has held up relatively well in the recession, and the ability to reinvest the proceeds in areas where valuations have been harder-hit by the downturn. Diageo would strengthen its position in the luxury end of the spirits business market near the bottom of the economic cycle, thus leaving itself well placed to benefit from a return to trading up as the world economy recovers.
The value of MH as a whole is put at “up to nearly 3 times” sales by the FT. With sales having been E3.13bn (£2.76bn) in 2008, this implies a value of up to E9.4bn (£8.3bn). Of course, with Diageo already owning 34% of MH, the cost to it would be “only” E6.2bn (£5.5bn) on this basis.
The Telegraph puts the value of MH at E12bn (£10.6bn). On this basis the deal would cost Diageo £7bn.
We suspect that the actual number could be even higher. MH makes very high (34%) EBIT margins, even by the standards of the spirits industry. Its 2008 EBIT was therefore E1,060m, implying a CAMP (contribution after marketing and promotion) of c.E1.6bn. With previous deals in the spirits industry being struck at CAMP
With the savings from this deal likely to be far lower than in previous deals due to the existing distribution overlap, and with only one realistic buyer for the business, we do not expect the valuation to be as high as this. But, as with previous deals, we believe that the price would surprise the market on the upside.
The Telegraph reports that Diageo would pay with “all cash, supported by a potential capital raising”. Diageo currently has net debt/EBITDA of 2.5x, and net debt of £7.9bn within a total EV of £27.6bn (both FY2009E numbers), both of which are relatively low by industry standards. We therefore believe that Diageo would look to fund a significant proportion of the deal through debt. We therefore (very provisionally) estimate the size of the likely rights issue at c.50% of the price paid (so £2.75bn on the FT valuation, £3.5bn on the Telegraph valuation, and £4.6bn at the lower end of our hypothetical valuation range based on previous deal multiples).
of Moët Hennessy that it does not own. The group has held this stake since 1994. The FT
indicates that LVMH and Diageo are currently involved in informal talks but this information
has been denied by LVMH.
We note that Diageo owns 33.3% of MH along with a put, with an exercise price that is not
very favourable for Diageo, corresponding to 80% of the fair value of the stake i.e. €2.9bn
at 31 December 2008 on the LVMH balance sheet or €10.9bn for 100% at fair value.
There is a 6-month notice period for the put.
valuation of the 66% held by LVMH in our SOP model comes to €6.6bn, based on average
EV/EBIT multiples in the beverages sector over 2008/2011e (10x on average), or around
€10bn for 100%, close to the fair value of the put. In the event of a transaction, a high
premium is likely: at 15x 2009 EV/EVIT, the price would come to €14.6bn for 100% of MH.
We have adopted a cautious stance on these rumours, which come just ahead of LVMH’s
Q1 09 sales report this evening after trading, although they do include some detailed
Roche and Genentech remain committed to Avastin adjuvant programs
Roche today announced the results of the first phase III trial evaluating the use of Avastin (bevacizumab) plus chemotherapy (FOLFOX) for the treatment of colon cancer immediately following surgery (adjuvant therapy) compared to chemotherapy alone. The study, known as NSABP
C-08, did not meet its primary endpoint of lowering the risk of the cancer returning (disease-free survival). This is the first trial of Avastin in early-stage cancer and results do not affect approved indications in advanced (metastatic) disease.
Safety findings were consistent with those presented from this study at the 2008 American Society of Clinical Oncology (ASCO) annual meeting (Allegra et al.)
failed to meet its primary endpoint. While disappointing, we had been cautious on
the chance of success and had included no sales for adjuvant in forecasts. Our
2014E Avastin forecast of CHF9.8bn is therefore unchanged as is our CHF190
PO. We would use any share price weakness on news to Buy given Roche’s
attractive valuation, expected upcoming guidance upgrade and other pipeline
catalysts.
Should not impact existing Avastin franchise
Avastin adjuvant colorectal cancer C08 trial failed to meet its primary endpoint (disease-free survival). Avastin as a whole is worth CHF65/share in our group NPV, with total adjuvant use (also including breast and lung cancer) worth around CHF7. Given this data it is fair to remove most or all of that potential adjuvant value. This data should not significantly impact Avastin’s current franchise. The adjuvant trial reported today was the first Phase III trial using of Avastin plus chemotherapy (FOLFOX) to treat colon cancer immediately following surgery (adjuvant therapy) compared to chemotherapy alone.
failure of the C-08 adjuvant Avastin trial is much as we
anticipated (When SFr10bn Is Not Enough, March 5,
2009), given that Roche closed yesterday at a c.36%
premium to the EU sector multiple. Consistent with our
long-term view, we believe that this creates buying
opportunities for investors to enter the stock at attractive
valuations. We therefore reiterate our Overweight rating.
The stock is trading 27% below our SFr189 intrinsic
value. We ascribed only a 40% probability of success
for C-08. Value from other adjuvant indications rightly
remains a free call option. We believe that the outlook
for phase III data in metastatic ovarian and prostate
cancers could provide meaningful upside to consensus
in 2H09.
adjuvant colorectal cancer failed to meet its primary
endpoint. The key issues are:
1) Risk to in-market Avastin revenues. Erbitux
and Vectibix in the metastatic setting with COIN
and PRIME data are to be presented at ASCO
in May/June 2009. We see limited impact on
Avastin usage from these EGFR agents.
2) Pricing pressure on Avastin post C-08. While
bears would cite increased vulnerability to
pushback from payors, we believe that
significant price reductions in EU are unlikely
and already priced into the stock. US usage
warrants continued scrutiny.
What’s next: Avastin data in metastatic ovarian and
prostate cancer (2H09) with up to $2bn/annum upside.
Al-Watan newspaper said in an unsourced report that a United Arab Emirates-Kuwait consortium was close to securing a deal to buy the world’s largest maker of business jets, offering $21 a share. It did not identify the companies.
The New York Stock Exchange said in a statement it had asked Textron to “issue a public statement indicating whether there are any corporate developments which may explain the unusual activity” but that the company said its policy is not to comment on market rumors.
The report comes in a week when Textron’s beaten-down shares have climbed roughly 80 percent, a rally that started on Monday amid speculation that Lockheed Martin Co , the world’s No. 1 defense contractor, or its smaller rival Raytheon Co were possible buyers for the company.
Lockheed and Raytheon officials on Monday declined to comment on those reports.
“Compared with earlier press speculation that has focused on large defense contractors as potential acquirers of Textron, the interest from a Middle East consortium would appear to make more sense,” Macquarie Capital analyst Robert Stallard wrote in a note to clients.
Textron shares were up $4.31 to $13.42 in afternoon trading on the New York Stock Exchange. Over the past year, they have fallen 84 percent, a steeper drop than the 55 percent decline in the Standard & Poor’s capital goods industry index < .GSPIC>.
Given the pounding of the shares, management might have a hard time resisting serious takeover bids, an analyst wrote.
“Given the legacy of execution issues at Textron, high investor dissatisfaction with recent company performance and continued liquidity uncertainty, a legitimate takeover attempt will be hard to resist,” wrote Citigroup analyst Jeffrey Sprague, in a note to clients.
According to the newspaper report, the consortium of buyers would plan to sell off Textron’s military businesses — Bell helicopter and Textron Systems, which makes armored vehicles. That could help to alleviate the national security concerns that could be triggered if a foreign buyer tried to buy a U.S. defense contractor
“A more obvious reason we do not believe any company would be interested in acquiring Textron is Textron Financial, which over the last year or so has been the primary cause of value destruction at the company, in our view, and remains a significant question mark for investors,” Susquehanna Financial Group analyst Stephen Velgot wrote in a note to clients.
In February, Textron Chief Executive Lewis Campbell said the company would consider selling one of its core units if it needed to do so to protect cash flow, though he argued it would be unlikely that it would need to make such a drastic move.
In March, the president of United Technologies Corp’s Sikorsky helicopter unit said it would be “an interesting hypothesis” for his business to take over Textron’s helicopter arm.
possible offer from a UAE consortium begin to
re-balance the risk/reward trade-off for TXT. Deal
speculation could prolong the recent rally, with
meaningful downside risk remaining if takeover interest
wanes heading into April earnings where TFC results
likely remain a concern. TXT still faces significant
questions around 2010 liquidity related to the unwinding
of its TFC portfolio. If deal speculation subsides, market
focus likely will again shift to TFC and once again weigh
upon the stock. The story was initially reported in
Al-Watan, a Kuwaiti newspaper, last Thursday, and was
subsequently reported by the Financial Times and the
Wall Street Journal. Textron has not commented.
foreign entity would not be allowed given TXT’s
participation in critical defense technologies, most
meaningfully helicopters. Any potential UAE consortium
takeover will most likely require a U.S. partner, with the
largest U.S. defense primes all capable of acquiring
TXT’s defense businesses, either in parts or as a whole.
Under this scenario, we do not foresee HSR concerns
regarding a U.S. acquisition of TXT Systems and other
defense components of the TXT portfolio.
Investment thesis: Short-term deal speculation could
continue to drive the stock; however if M&A speculation
subsides, market focus will shift to first quarter results
and the status of the TFC unwind.
morning (in a story also repeated by French news agency AFP and Bloomberg)
that a consortium of United Arab Emirates companies and a Kuwaiti firm are
planning an offer to purchase Textron for $21 per share ($5.07 billion), a
130.5% premium to yesterday’s closing price. This offer represents 5.3x
2009E EBITDA and .43x sales.
is specifically interested in Textron’s “civil industries”, which we believe would
primarily target Cessna. The defense operations would reportedly be sold to a
US company. This type of scenario would likely solve one of the key problems
in realizing TXT’s full value, namely that TXT has many pieces which would fit
well with other companies, but all of TXT does not fit well with any one
company. Clearly the US government would not let Bell or Systems fall into
foreign hands, in our view. However, it does seem possible that a deal could
be struck to carve out these pieces until a US bidder emerged. UTX and
Boeing would have high interest in Bell, in our view, and Systems could attract
numerous Defense bidders. We suspect this investor group would also look to
sell non core Industrial assets and liquidate TFC.
worst case scenario suggests Textron’s portfolio is worth a minimum of $15 per
share using current depressed valuations. The valuation is complicated by
uncertainty over the true long term losses at TFC. However, looking at the
quality and strategic value of TXT’s aero and defense assets, we do think a
price north of $20 is supportable if buyers are taking a more normalized view.
Deal Overtures Will Be Hard To Resist — Given the legacy of execution issues
at TXT, high investor dissatisfaction with recent company performance and
continued liquidity uncertainty, a legitimate takeover attempt will be hard to
resist. Our thesis has been that the wreckage in the stock would create its own
catalysts and that now seems to be happening. We maintain our Buy rating,
but if the stock moves into the high teens we could become more cautious.
12:00 22Apr09 RTRS-GLAXOSMITHKLINE PLC – DELIVERS Q1 EPS OF 26.3P BEFORE MAJOR RESTRUCTURING
12:00 22Apr09 RTRS-GLAXOSMITHKLINE SAYS Q1 EPS BEFORE MAJOR RESTRUCTURING COSTS 26.3P (REUTERS CONSENSUS MEAN WAS 28.4 P)
12:00 22Apr09 RTRS-GLAXOSMITHKLINE PLC – INCREASED DIVIDEND OF 14P
12:00 22Apr09 RTRS-GLAXOSMITHKLINE PLC – Q1 SERETIDE/ADVAIR SALES WERE LEVEL AT £1.2 BILLION
12:00 22Apr09 RTRS-GLAXOSMITHKLINE PLC – Q1 PROFIT PERFORMANCE ADVERSELY IMPACTED BY GROSS MARGIN DECLINE DUE TO US GENERIC COMPETITION
12:00 22Apr09 RTRS-GLAXOSMITHKLINE PLC – TERMINATING ROSIGLITAZONE XR STUDY IN ALZHEIMER’S, MOVING MAGE-A3 INTO PHASE III STUDY FOR MELANOMA
Carphone Warehouse’s Q4 trading statement indicates that EPS for FY2009E and FY2010E will be broadly in line with expectations although the statement indicates that the company has achieved a better than expected performance at TalkTalk UK in terms of subscriber growth and a better than expected performance at Best Buy Europe in terms of connections albeit with a weaker performance in contract connections. We anticipate making no material changes to P&L our estimates, although we may upgrade our cashflow expectations. On the whole, this appears a solid statement albeit we would argue this has been discounted by the very strong share price performance year to date.
Strategic review. The company has indicated that it has completed its initial review of the company and ‘believes a demerger structure can be achieved to create two separately listed companies’. It is intended that Charles Dunstone will become chairman of each company. The company has indicated that ‘the timing of any demerger will depend on the cost and reallocation of the Group’s credit facilities.’
Net debt. The statement indicates that effective net debt at March 2009 was £180m. This is slightly below our forecast for £195m and the consensus at £184m.
Fixed line performance. TalkTalk UK has reported a closing broadband base of 2,806k (+3%, y.o.y.) which is ahead of our forecast of 2,777k and the consensus expectation for 2,778k. This implies that the division has achieved net adds of 74k (+32%, y.o.y.) in Q4 versus our expectation for 45k and the consensus at 46k. The division reported that 78% of its broadband customers have been unbundled versus our expectation for 80% and 78% at the end of Q3.
Best Buy Europe. The division reported total connections of 3,019k which is well ahead of our forecast of 2,778k and the consensus at 2,704k. Of these, 1,130k were subscription customers which is below our forecast of 1,151k but ahead of the consensus at 1,104k
Valuation. At 127p, CPW trades on a CY2009E PER of 10.0x, versus the European Telecoms Sector on 8.5x. The shares trade broadly in line with a blended Telecoms and retail PER of 9.9x. We retain our IN-LINE recommendation.
Apparently, the communists behind this blog are being sued by Goldman Sachs. But that is not the whole story. I can reveal that Goldman has actually commissioned me to put a curse on the blog. The bank is paying me an obscene amount of money for this service, but I would have done it for free.
